Related Experiment Video
Updated: Apr 23, 2026
Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies
Published on: January 31, 2013
What do mouse models of muscular dystrophy tell us about the DAPC and its components?
Charlotte Whitmore1, Jennifer Morgan
1Dubowitz Neuromuscular Centre, Molecular Neurosciences Section, Developmental Neurosciences Programme, Institute of Child Health, University College London, London, UK.
Abstract:
There are over 30 mouse models with mutations or inactivations in the dystrophin-associated protein complex. This complex is thought to play a crucial role in the functioning of muscle, as both a shock absorber and signalling centre, although its role in the pathogenesis of muscular dystrophy is not fully understood. The first mouse model of muscular dystrophy to be identified with a mutation in a component of the dystrophin-associated complex (dystrophin) was the mdx mouse in 1984. Here, we evaluate the key characteristics of the mdx in comparison with other mouse mutants with inactivations in DAPC components, along with key modifiers of the disease phenotype. By discussing the differences between the individual phenotypes, we show that the functioning of the DAPC and consequently its role in the pathogenesis is more complicated than perhaps currently appreciated.
Insights
Researchers compared over 30 mouse models with genetic changes in the dystrophin-associated protein complex (DAPC). This study reveals the DAPC
Area of Science:
- Muscle biology
- Genetics
- Pathogenesis of muscular dystrophy
Background:
- The dystrophin-associated protein complex (DAPC) is vital for muscle function, acting as a shock absorber and signaling hub.
- Its precise role in muscular dystrophy pathogenesis remains incompletely understood.
- Over 30 mouse models with DAPC mutations exist, offering valuable tools for research.
Purpose of the Study:
- To evaluate key characteristics of the mdx mouse model.
- To compare the mdx mouse with other DAPC component inactivation mutants.
- To identify key modifiers of the muscular dystrophy phenotype in these models.
Main Methods:
- Comparative analysis of phenotypic characteristics across various DAPC mutant mouse models.
- Evaluation of disease modifiers impacting muscular dystrophy phenotypes.
- Detailed examination of the mdx mouse model in relation to other DAPC mutants.
Main Results:
- Significant phenotypic differences were observed among distinct DAPC inactivation mutants.
- The mdx mouse model exhibits specific characteristics when compared to other DAPC mutants.
- Key genetic and environmental modifiers influence the observed disease phenotypes.
Conclusions:
- The functional complexity of the DAPC is greater than previously appreciated.
- Understanding DAPC component interactions is crucial for elucidating muscular dystrophy pathogenesis.
- Comparative studies of DAPC mouse models provide insights into disease mechanisms.
